GH Capital’s Vitana-X to Expand to Germany and Make Available in the 2nd Largest European Country
GH Capital, through its Vitana-X subsidiary, is expanding to Germany, tapping into a market of over 83 million people. This move represents a major opportunity for revenue growth. Highlighting their entry, the upcoming Vitana-X German Open on September 5th in Munich will feature health and business leaders. The event aims to boost brand visibility and sales. Vitana-X will showcase its new product line, Vita-Pure, and share scientific advancements to support healthier living. This strategic expansion is set to enhance the company’s market presence in Europe.
- Expansion into Germany's market of over 83 million people presents a significant revenue opportunity.
- Participation in the Vitana-X German Open event will enhance brand exposure.
- Introduction of the new Vita-Pure product line expected to attract consumer interest.
- None.
Great Opportunity to Increase Revenue to Germany's 83 Million People
MIAMI, FL / ACCESSWIRE / September 1, 2020 / GH Capital, Inc. (OTC Pink:GHHC), through its Vitana-X subsidiary, a provider of comprehensive programs for greater well-being, fitness and health with a wellness network marketing program, is pleased to announce its entry into Germany. Vitana-X's expansion to Germany, Europe's second largest country in regards to population, represents a great opportunity to increase revenue with its exposure to the country's more than 83 million people.
On Saturday, September 5th, the "Vitana-X German Open" will take place in Munich, Germany. Celebrities and experts from the fields of health, sports, business and science are expected to participate. This event will highlight a strategic get-together, especially for many international Vitana-X business partners, with the goal of increasing awareness, visibility and sales.
"We have prepared ourselves for many months for this very special moment, now the time has come: Vitana-X is presenting itself to an international audience for the first time on a large floor," stated, Bernhard Sammer, Co-Founder of Vitana-X. "Of note, our product developers and laboratories recently confirmed the crucial delivery dates for our new product launches. We will be presenting the new and expanded "Vita-Pure" product line for the first time in history. We have a lot to be excited about and look forward to keeping our partners, customers and shareholders updated.
Well-known leaders and executives from more than 10 different nations are registered for this event. The science team from the Swiss development laboratory will also take part at a public live event for the very first time and will share their latest findings and developments. An extraordinarily important day in terms of both strategy and content.
About GH Capital / Vitana-X
GH Capital, Inc.'s (OTC:GHHC) Vitana-X, an international wellness company specializing in the development and manufacture of health-promoting products based on DNA analysis. As a pioneer in this industry and a worldwide network of highly qualified experts, it offers its customers extensive opportunities to lead a healthier life. Vitana-X offers comprehensive programs for greater well-being, fitness and health by helping you achieve the desired results and offering exercises that fit your body type. Vitana-X wants to support people in their healthy development and be their reliable partner for their full potential. Vitana-X comes from two worlds and wants to unite them in the future - science and the challenges of daily life, so that its customers can continue to care for other areas of life without sacrificing a healthy life.
For additional information on Vitana-X, please visit: http://vitana-x.net.
Forward-Looking Statements
Forward-Looking Statements. This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words "believe," "anticipate," "estimate," "expect," "intend," "plan," "project," "prospects," "outlook," and similar words or expressions, or future or conditional verbs such as "will," "should," "would," "may," and "could" are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any anticipated results, performance or achievements. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company's forward-looking statements, please see the Company's Form 10-K filed on December 28, 2019, for the fiscal year ended September 30, 2018, including but not limited to the discussion under "Risk Factors" therein, which the Company has filed with the SEC and which may be viewed at http://www.sec.gov.
Contact Information
press@ghcapital-inc.us
305-714-9397
SOURCE: GH Capital, Inc.
View source version on accesswire.com:
https://www.accesswire.com/604261/GH-Capitals-Vitana-X-to-Expand-to-Germany-and-Make-Available-in-the-2nd-Largest-European-Country
FAQ
What is GH Capital's recent expansion effort in Germany?
When is the Vitana-X German Open scheduled?
What new products will Vitana-X launch in Germany?
How does the German market impact GH Capital (GHHC)?
